Resumen de acción PBH
Prestige Consumer Healthcare Inc., junto con sus filiales, desarrolla, fabrica, comercializa, distribuye y vende productos de venta libre para la salud y el cuidado personal en Estados Unidos y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Competidores de Prestige Consumer Healthcare Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$70.47 |
| 52 Week High | US$75.31 |
| 52 Week Low | US$52.90 |
| Beta | 0.53 |
| 1 Month Change | -2.88% |
| 3 Month Change | 10.98% |
| 1 Year Change | 14.53% |
| 3 Year Change | 61.78% |
| 5 Year Change | 137.27% |
| Change since IPO | 297.01% |
Noticias y actualizaciones recientes
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly
Mar 26
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued
Mar 05Recent updates
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly
Mar 26An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued
Mar 05Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Feb 11Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon
Feb 05Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly
Dec 14Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly
Sep 10Prestige Consumer Healthcare: Unproductive Buyback And Excessive Valuation
Aug 15Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?
Jun 12An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued
May 20Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors
Mar 17Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly
Mar 02Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price
Feb 08Prestige Consumer Healthcare reports Q3 earnings beat; updates FY23 guidance
Feb 02Prestige Consumer Healthcare: Taking My Winnings Off The Table
Jan 19Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly
Nov 23Prestige Consumer Healthcare GAAP EPS of $1.02 beats by $0.02, revenue of $289.3M beats by $6.07M
Nov 03Holding Prestige Consumer Healthcare
Aug 31If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity
Aug 26We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt
Aug 05Prestige Consumer Healthcare GAAP EPS of $1.09 beats by $0.05, revenue of $277.1M beats by $8.18M
Aug 04Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?
May 27Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?
May 05Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?
Feb 22Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?
Feb 03These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively
Nov 04Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden
Aug 06Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 50% Below Their Intrinsic Value Estimate
Jun 14Prestige Consumer Healthcare Inc. 2021 Q4 - Results - Earnings Call Presentation
May 08These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively
Apr 19How Much Did Prestige Consumer Healthcare's (NYSE:PBH) CEO Pocket Last Year?
Feb 22Rentabilidad de los accionistas
| PBH | US Pharmaceuticals | Mercado US | |
|---|---|---|---|
| 7D | 1.1% | 0.7% | 2.9% |
| 1Y | 14.5% | 10.8% | 22.2% |
Rentabilidad vs. Industria: PBH superó al sector US Pharmaceuticals , que obtuvo un rendimiento del 10.6% el año pasado.
Rentabilidad vs. Mercado: PBH obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.
Volatilidad de los precios
| PBH volatility | |
|---|---|
| PBH Average Weekly Movement | 3.6% |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: PBH no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: PBH's weekly volatility (4%) has been stable over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1996 | 560 | Ron Lombardi | www.prestigebrands.com |
Prestige Consumer Healthcare Inc., junto con sus filiales, desarrolla, fabrica, comercializa, distribuye y vende productos sanitarios y de cuidado personal de venta libre (OTC) en Estados Unidos y a escala internacional. La empresa opera en dos segmentos, OTC Healthcare norteamericano y OTC Healthcare internacional. Ofrece polvos analgésicos BC/Goody's, pomadas para bebés Boudreaux's Butt Paste, líquidos y pastillas para el dolor de garganta Chloraseptic, Clear Eyes para el alivio del enrojecimiento ocular, Compound W para la eliminación de verrugas, DenTek para el cuidado bucal PEG, Debrox para la eliminación de la cera de los oídos y Dramamine para el alivio del mareo.
Resumen de fundamentos de Prestige Consumer Healthcare Inc.
| Estadísticas fundamentales de PBH | |
|---|---|
| Capitalización bursátil | US$3.50b |
| Beneficios(TTM) | -US$80.67m |
| Ingresos (TTM) | US$1.13b |
3.1x
Ratio precio-ventas (PS)-43.4x
Ratio precio-beneficio (PE)¿Está PBH sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de PBH | |
|---|---|
| Ingresos | US$1.13b |
| Coste de los ingresos | US$500.02m |
| Beneficio bruto | US$634.21m |
| Otros gastos | US$714.88m |
| Beneficios | -US$80.67m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
May 14, 2024
| Beneficios por acción (BPA) | -1.62 |
| Margen bruto | 55.92% |
| Margen de beneficio neto | -7.11% |
| Ratio deuda/patrimonio | 74.9% |
¿Cómo se ha desempeñado PBH a largo plazo?
Ver rendimiento histórico y comparativa